Medical Technology
2020
Will Klippgen
Singapore
Overview
ArrowBiome is a Singapore-based biotech company advancing precise bacterial targeting with proprietary technologies. Spun out from Singapore-MIT Alliance for Research and Technology (SMART) and NTU Lee Kong Chian School of Medicine, their proprietary platform technologies enable highly-selective bacterial targeting and killing. ArrowBiome provides superior solutions to many applications, including skin conditions caused by bacteria such as acne and body odour, gut health, and antimicrobial resistance.
Visit websiteThe ArrowBiome team
Boon Chong Goh
PhD - CTO & Founder
Boon Chong Goh is the CTO and Founder of ArrowBiome. During his tenure as a principal researcher at the Singapore-MIT Alliance for Research and Technology (SMART) in Singapore, Dr. Goh developed two technology platforms for selective microbiome control by combining his expertise in microbiology, structural biology, computational biophysics, drug discovery and protein biochemistry. He was awarded with 4 national grants as the lead principal investigator, and led a drug discovery campaign in SMART and NTU to develop new drugs targeting antibiotic-resistant bacteria using structure based drug designs and whole-cell phenotypic screening.
Bert Grobben
PhD - CEO
Dr. Bert Grobben is a global leader in strategic foresight, open innovation, and venture building. With over 25 years of innovation leadership across multinational corporations and early-stage deep-tech startups, Dr. Grobben has managed innovation portfolios exceeding US$100 million and delivered commercial outcomes for billion-dollar brands. During his leadership roles at P&G and Avery Dennison, he developed deep expertise in translating consumer and market insights into strategic business opportunities, product innovation, and brand growth across global markets. With a PhD in Biomedical Sciences, he is committed to preventive health, sustainability, and healthy living, and supports SMEs and startups in refining product-market fit, go-to-market strategies, and business model innovation.